Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
Indian Journal of Ophthalmology · 2023-04 · 71 (4) · 1285-1291
DOI: 10.4103/ijo.ijo_2912_22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Journal of Ophthalmology, online erschienen am 05.04.2023. Verfasst von Nallathambi Jeyabalan und 5 weiteren Autor:innen. Beteiligte Einrichtung: GROW Research Laboratory, Narayana Nethralaya Foundation, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Autophagy, Dry Eye Syndromes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Dry eye disease (DED) is a chronic ocular surface disorder, associated with inflammation, which can cause severe morbidity, visual compromise, and loss of quality of life, affecting up to 5–50% of the world population. In DED, ocular surface damage and tear film instability due to abnormal tear secretion lead to ocular surface pain, discomfort, and epithelial barrier disruption. Studies have shown the involvement of autophagy regulation in dry eye disease as a pathogenic mechanism along with the inflammatory response. Autophagy is a self-degradation pathway in mammalian cells that reduces the excessive inflammation driven by the secretion of inflammatory factors in tears. Specific autophagy modulators are already available for the management of DED currently. However, growing studies on autophagy regulation in DED might further encourage the development of autophagy modulating drugs that reduce the pathological response at the ocular surface. In this review, we summarize the role of autophagy in the pathogenesis of dry eye disease and explore its therapeutic application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GROW Research Laboratory, Narayana Nethralaya Foundation, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India.
- Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India.
- Harry S. Truman Memorial Veterans' Hospital; Departments of Veterinary Medicine and Surgery and Biomedical Sciences, University of Missouri; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO,…
Zitieren
APA
Jeyabalan, N., Pillai, A. M., Khamar, P., Shetty, R., Mohan, R. R., & Ghosh, A. (2023). Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface. Indian Journal of Ophthalmology, 71(4), 1285-1291. https://doi.org/10.4103/ijo.ijo_2912_22
Vancouver
Jeyabalan N, Pillai AM, Khamar P, Shetty R, Mohan RR, Ghosh A. Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface. Indian Journal of Ophthalmology. 2023;71(4):1285-1291. doi:10.4103/ijo.ijo_2912_22
BibTeX
@article{Jeyabalan2023,
author = {Jeyabalan, Nallathambi and Pillai, Aswathi M and Khamar, Pooja and Shetty, Rohit and Mohan, Rajiv R and Ghosh, Arkasubhra},
title = {Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface},
journal = {Indian Journal of Ophthalmology},
year = {2023},
volume = {71},
number = {4},
pages = {1285--1291},
doi = {10.4103/ijo.ijo_2912_22}
}
EUVIMED